TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06584409

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Observation
Description: Sham treatment with no laser output, stimulate the same acupoints as laser acupuncture group as follows: 30 seconds at bilateral Cuanzhu (BL2), Fengchi (GB20), Taiyang (EX-HN5), Shuaigu (GB8), Hegu (LI4), Taichong (LR3) and midline Yintang (EX-HN3)~After 6 months followed up, the sham group received truely Laser stimulation energy of 4.5 J for 30 seconds at each of the following acupoints: bilateral Cuanzhu (BL2), Fengchi (GB20), Taiyang (EX-HN5), Shuaigu (GB8), Hegu (LI4), Taichong (LR3) and midline Yintang (EX-HN3), and followed up for another 3 months.
Study: NCT06268717

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ground pork containing alpha-gal
Description: 150 grams of cooked, ground pork meat containing alpha-gal sugar eaten once

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ground pork containing alpha-gal
Description: 150 grams of cooked, ground pork meat containing alpha-gal sugar eaten once

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pork meat not containing alpha-gal
Description: 150 grams of cooked, ground pork meat not containing alpha-gal sugar
Study: NCT05820295

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Care coordination delivered based on perceived need
Description: If patients in intervention group report on the survey that they experience difficulty coordinating care among their providers, the patient will be selected for care management services. Those services will attempt to address the problems with care coordination that the proxy reported.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Care coordination delivered based on usual care (e.g. discharge from hospital)
Description: If a patient is discharged from a hospital, the patient will be selected for care management services.
Study: NCT04952389

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupuncture Therapy
Description: Consists of two treatments per week for five weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Budesonide
Description: Twice daily nasal rinses with steroid medication (budesonide)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Budesonide
Description: Twice daily nasal rinses with steroid medication (budesonide)
Study: NCT06268717

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pork meat not containing alpha-gal
Description: 150 grams of cooked, ground pork meat not containing alpha-gal sugar
Study: NCT06351267

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core Stability Exercises
Description: Core stability exercises will be used to strengthen the core muscles, which includes sets of exercises like pelvic tilts, wall squatting, bridging, bird dog and heel walking which targets core muscles.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Back Strengthening exercises
Description: Back strengthening exercises will be used to strengthen the back muscles which include sets of exercises that target back muscles like cat-cow exercise, child pose, heel sits, and kegels.
Study: NCT04216290

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy of Bladder
Description: Undergo bladder biopsy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biopsy of Bladder
Description: Undergo bladder biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy of Bladder
Description: Undergo bladder biopsy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biopsy of Bladder
Description: Undergo bladder biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo tumor tissue and blood sample collection

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo tumor tissue and blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo tumor tissue and blood sample collection

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo tumor tissue and blood sample collection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT
Study: NCT04952389

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Olfactory Training
Description: involves smelling 4 different essential oils (e.g. rose, lemon, clove, and eucalyptus) twice a day for 20 seconds each (after the nasal rinse)
Study: NCT04216290

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT
Study: NCT04952389

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Olfactory Training
Description: involves smelling 4 different essential oils (e.g. rose, lemon, clove, and eucalyptus) twice a day for 20 seconds each (after the nasal rinse)
Study: NCT04216290

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cystoscopy
Description: Undergo cystoscopy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cystoscopy
Description: Undergo cystoscopy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cystoscopy
Description: Undergo cystoscopy

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cystoscopy
Description: Undergo cystoscopy

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorouracil
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluorouracil
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine Hydrochloride
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine Hydrochloride
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mitomycin
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mitomycin
Description: Given IV

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient Observation
Description: Undergo observation

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo radiation therapy

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation Therapy
Description: Undergo radiation therapy
Study: NCT05385614

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: de:)press
Description: Patients will receive de:)press for the duration of six weeks. They will be encourages to use the app at least three times a week, up to once per day.
Study: NCT06344520

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: pektoralis minor shortnes
Description: One factor that is effective in acceleration during swimming is the force of the arm pulling the water. While the pectoralis minor muscle pulls the crocoid process forward, it pulls its posterolateral corner down, which helps the latismus dorsi to make an extension movement and the lower trapezius to depress the scapula. When the pectoralis minor muscle is short, it prevents maximum reach in the arm because its full function cannot be revealed. It is thought that depression of the scapula will directly affect acceleration in swimming, as it increases the backward thrust of the arm.

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Group in which the Pectoralis Minor stretching exercise was performed in a sham manner
Description: In most cases, exercise practices also affect the person psychologically. In order to ignore the psychological effects of the exercises, they were made to perform exercises that were similar to pectoralis minor stretching exercises but did not activate the muscle

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The group in which Pectoralis Minor stretching exercise was not applied
Description: The Control Group was not given any exercise and they continued to do their own training.
Study: NCT05367804

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Isolated pea protein
Description: The subjects eligible to take part in this study will consume an isolated plant protein for 4 weeks (week 4 to 8), in each week the amount of protein supplementation will increase (0.25 to 1.0 g of protein per kg of body weight). The protein will be provided as a powder in opaque bags and participants will be instructed to dissolve the contained powder in liquids (as water) or on their food (e.g., yogurt, oat porridge). The baseline will consist of 4 visits (1 to 4) to see how stable are the baseline results.
Study: NCT05839990

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery
Description: Replacement of the ascending aorta in case of anerysm and dilatation
Study: NCT05070949

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful Self-Compassion
Description: Bi-weekly meeting will involve six lessons: What is Self-Compassion , Practicing Self-Compassion, Discovering your Compassionate Voice, Self-Compassion and Resilience , Self-Compassion and Burnout and Making it Count
Study: NCT06005493

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD5863
Description: T cell-engaging bi-specific antibody that targets CLDN18.2 (Claudin18.2) on tumor cells and CD3 on T cells

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD5863
Description: T cell-engaging bi-specific antibody that targets CLDN18.2 (Claudin18.2) on tumor cells and CD3 on T cells
Study: NCT05864157

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Gait training without rhythmic auditory cues
Description: Gait training on treadmill and overground without any rhythmic auditory cues

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TRAC
Description: Metronome set to 85% on treadmill and 115% when walking overground

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dTRAC
Description: Metronome set around 85% on treadmill and around 115% when walking overground
Study: NCT05297305

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tornier Ascend Flex stem
Description: Reverse Total Shoulder Arthroplasty using onlay component (tray placed at top of humerus)
Study: NCT06427941

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BGB-B2033
Description: Administered by intravenous infusion
Study: NCT05297305

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tornier Perform Stem Reverse+
Description: Reverse Total Shoulder Arthroplasty using inlay component (tray placed in humerus)
Study: NCT06427941

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BGB-B2033
Description: Administered by intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Administered by intravenous infusion
Study: NCT06189495

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GenSci048
Description: 1. Dosage: 300 mg.2. Duration of administration: All subjects received one dose of Genakumab injection every 4 weeks according to their group.The dose was injected subcutaneously.3. Course of administration: Phase I subjects were treated with Genakumab injection until the end of the study or the occurrence of the drug.Tolerable toxicity or investigator-assessed efficacy (whichever occurs first); The phase 2 randomized double-blind treatment period was 24 weeks, with a total of 6 administration times. After the randomized double-blind treatment period, an open-label treatment period was entered, and all subjects will receive Genakumab injection 300 mg Q4W until the end of the study or the occurrence of intolerable toxicity or poor efficacy assessed by the investigators (whichever occurs first).4. Administration method: subcutaneous injection; The injection site is the abdomen (3 cm away from the navel

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: GenSci048 placebo
Description: 1. Dosage: 300 mg.2. Duration of administration: All subjects received one dose of placebo every 4 weeks according to their group The dose was injected subcutaneously.3. Course of administration: Phase I subjects were treated with placebo until the end of the study or the occurrence of the drug.Tolerable toxicity or investigator-assessed efficacy (whichever occurs first); The phase 2 randomized double-blind treatment period was 24 weeks, with a total of 6 administration times. After the randomized double-blind treatment period, an open-label treatment period was entered, and all subjects will receive placebo 300 mg Q4W until the end of the study or the occurrence of intolerable toxicity or poor efficacy assessed by the investigators (whichever occurs first).~4. Administration method: subcutaneous injection; The injection site is the abdomen (3 cm away from the navel)
Study: NCT05727670

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: exposure of the tooth crown
Description: surgical exposure of the crown of a retentive tooth
Study: NCT06206876

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DDX5 Degrader FL118
Description: Given PO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study: NCT05431010

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electroacupuncture
Description: Participants are required to be in the supine position. Routine disinfection first. Participants are then subjected to acupuncture and achieve deqi sensation at all acupuncture points. Four paired of acupuncture points (i.e. Biguan acupoints and Futu points; Yanglingquan acupoints and Zusanli acupoints, identical on both sides) are connected to the EA devices. EA parameter is set as sparse wave and frequency is 2Hz. The intensity of the EA is determined by the patients' tolerance. Needles will be left in place and each session of EA will last 30 minutes. Participants will undergo a total of 36 EA sessions, with the frequency of 3 sessions every week for 12 weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rehabilitation Training
Description: The rehabilitation training group will be only treated with the Otago exercise program(OEP). Otago Exercise combines resistance exercise, balance training and aerobic walking and is an exercise prescription for elderly patients with sarcopenia.~1. Exercise: including warm-up exercise (5 minutes) + resistance exercise (20 minutes) + balance training (5 minutes). Training intensity: 30 minutes a day, 3 times a week, once every other day, 12 weeks of training period; resistance exercise gradually increases the load.~2. Walking program: Take a walk. Activity intensity: 30 minutes each time, 2 times a week, combined with exercise (walking during the interval between exercise sessions), 12 weeks of training period

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation Training
Description: The rehabilitation training group will be only treated with the Otago exercise program(OEP). Otago Exercise combines resistance exercise, balance training and aerobic walking and is an exercise prescription for elderly patients with sarcopenia.~1. Exercise: including warm-up exercise (5 minutes) + resistance exercise (20 minutes) + balance training (5 minutes). Training intensity: 30 minutes a day, 3 times a week, once every other day, 12 weeks of training period; resistance exercise gradually increases the load.~2. Walking program: Take a walk. Activity intensity: 30 minutes each time, 2 times a week, combined with exercise (walking during the interval between exercise sessions), 12 weeks of training period
Study: NCT04684485

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Tablet of SCD-044 product in subjects with moderate to severe atopic dermatitis.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SCD-044_Dose 1
Description: SCD-044 tablets of low dose (Dose 1) in subjects with moderate to severe atopic dermatitis.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SCD-044_Dose 2
Description: SCD-044 tablets of intermediate dose (Dose 2) in subjects with moderate to severe atopic dermatitis.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SCD-044_Dose 3
Description: SCD-044 tablets of high dose (Dose 3) in subjects with moderate to severe atopic dermatitis.
Study: NCT04601987

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Breastfeeding
Description: Counseling about the maternal health benefits of lactation.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Smokefree Homes
Description: Counseling about the importance of smoke-free homes.
Study: NCT05286151

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rhythm discrimination
Description: Participants will complete a rhythm discrimination task once per year for 3 years.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rhythm discrimination
Description: Participants will complete a rhythm discrimination task once per year for 3 years.
Study: NCT05750628

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INE963
Description: oral INE963

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INE963
Description: oral INE963

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INE963
Description: oral INE963
Study: NCT06284421

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Shore durometer
Description: The durometer will be held on the exterior of the lower uterine segment and fundus to measure the hardness reading at each location.
Study: NCT06132763

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hydration Intervention
Description: Teacher \& student ambassadors: serve as hydration role models, identify Hydration Heroes, monitor filter lights on hydration stations, \& update the water meter visual.~Kick-off event: event to kick off the hydration intervention to include water bottles distribution with a station to personalize, experiential activities, and information about the intervention.~Social marketing: student-developed marketing campaign Make water your superpower will be placed in high-traffic areas of the school. Hydration Headquarters will be located in the lunchroom displaying a water meter illustrating bottle refills from the school's hydration stations.~Behavioral reinforcement: on random days, students drinking water and/or with a water bottle will receive small incentives.~Education and outreach: Hydration Tip Sheets, hydration signage in classrooms, and hydration trivia on hydration stations. Teachers will deliver 1 hydration lesson per month that align with Standards of Learning.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control - Assessments Only
Description: Assessments only
Study: NCT05227651

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK104
Description: IV infusion,Specified dose on specified days
Study: NCT05750628

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INE963
Description: oral INE963

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KAE609 (Cipargamin)
Description: oral KAE609 (Cipargamin)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KAE609 (Cipargamin)
Description: oral KAE609 (Cipargamin)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KAE609 (Cipargamin)
Description: oral KAE609 (Cipargamin)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SoC (Coartem)
Description: SoC (Coartem)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SoC (Coartem)
Description: SoC (Coartem)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SoC (Coartem)
Description: SoC (Coartem)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KLU156
Description: oral sachet KLU156 (KAF156 + lumefantrine)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KLU156
Description: oral sachet KLU156 (KAF156 + lumefantrine)